| 1. |
- Ahlin, Cecilia, et al.
(författare)
-
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer
- 2009
-
Ingår i: Cancer Epidemiology, Biomarkers and Prevention. - 1055-9965 .- 1538-7755. ; 18:9, s. 2501-2506
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Proliferative markers are not recommended as prognostic factors for clinical use in breast cancer due to lack of standardization in methodology. However, proliferation is driving several gene expression signatures emphasizing the need for a reliable proliferative marker IF or clinical use. Studies suggest that cyclin A is a prognostic marker with satisfying reproducibility. We investigated cyclin A as a prognostic marker in node-negative breast cancer using previously defined cutoff values. Patients and Methods: In a case-control study, we defined 190 women who died from breast cancer as cases and 190 women alive at the time for the corresponding case's death as controls. Inclusion criteria were tumor size <= 50 mm, no lymph node metastases and no adjuvant chemotherapy. Tumor tissues were immunostained for cyclin A using commercially available antibodies. Results: We found a statistically significant association between expression of cyclin A and breast cancer death in a univariate model: odds ratio for cyclin A(ave) 2.7 [95% confidence interval (CI), 1.7-4.3] and cyclin A(max) 3.4 (CI, 2.1-5.5). Corresponding odds ratio for Ki67 were Ki67(ave) 1.9 (CI, 1.2-3.1) and Ki67(max) 1.7 (CI, 1.1-2.7) and for grade 3.1 (CI, 1.8-5.1). Cyclin A was strongly correlated to Ki67 and grade why a model including all was not appropriate. Conclusions: Cyclin A is a prognostic factor for breast cancer death in node-negative patients using standardized methodology regarding scoring and cutoff values. Adding cyclin A as a proliferative marker to established clinicopathologic factors will improve the separation of low and high risk breast cancer.
|
|
| 2. |
- Zhou, Wenjing, et al.
(författare)
-
Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution
- 2009
-
Ingår i: Molecular Oncology. - : Wiley. - 1574-7891. ; 3:3, s. 214-219
-
Tidskriftsartikel (refereegranskat)abstract
- In breast cancer, previous studies have suggested that somatic TP53 mutations are likely to be an early event. However, there are controversies regarding the cellular origin and linear course of breast cancer. The purpose of this study was to investigate tumor evolution in breast cancer by analyzing TP53 mutation status in tumors from various stages of the disease. The entire coding sequence of TP53 was sequenced in a cohort of pure ductal carcinoma in situ (DCIS), pure invasive cancer (
|
|
| 3. |
- Zhou, Yinhua, et al.
(författare)
-
Inverted and transparent polymer solar cells prepared with vacuum-free processing
- 2009
-
Ingår i: SOLAR ENERGY MATERIALS AND SOLAR CELLS. - : Elsevier BV. - 0927-0248. ; 93:4, s. 497-500
-
Tidskriftsartikel (refereegranskat)abstract
- Inverted transparent polymer solar cells were fabricated by sequentially depositing several organic layers from fluids, on ITO/glass substrates. ITO was used as a cathode to collect electrons. The photovoltage of these diodes can be increased by up to 400 mV by inserting a buffer layer of polyethylene oxide between ITO and the active layers, which results in 4-fold enhancement of power conversion efficiency under the illumination of 100 mW/cm(2) simulated AM1.5 solar light. The enhancement of V., is consistent with the work function change between ITO and ITO/PEO measured by photoelectron spectroscopy. Solar cell production without vacuum processing may lower production costs.
|
|
| 4. |
|
|
| 5. |
|
|
